Skip to content

CryoPort, Inc. CYRX Unrealized Gain (Loss) on Investments

Unrealized Gain (Loss) on Investments at other companies

TEC
Bio-TechneTECH
LeMaitre Vascular logo
LeMaitre VascularLMAT

Other financials

Income statement

See full
Revenue$47.8M+16.5%
Gross profit$21.9M+17.6%
Operating income-$9.6M-33.6%
Net income-$10.5M+12.0%
EPS (diluted)-$0.25+10.7%

Balance sheet

See full
Cash & equivalents$272.9M+656%
Total debt$230.7M+293%
Total equity$495.0M+24.1%
Total assets$763.6M+9.1%

Cash flow

See full
Operating cash flow$3.7M+186%
CapEx$10.0M+215%
Free cash flow-$6.2M+16.8%

Valuation

See full
Market cap$800.39M+151%
Enterprise value$758.23M+122%
P/E10.6×
P/S4.4×+2.4×

Profitability

See full
Gross margin47.2%+1.6pp
Operating margin-21.4%-8.8pp
Net margin39.2%+22.1pp
FCF margin-13%-3.6pp

Returns & leverage

See full
Return on equity14.5%+8.6pp
Debt / equity0.5×+0.3×
Current ratio2.1×-3.5×

Where this comes from

Reported directly by CryoPort, Inc. in its filing.

Tagged under the XBRL concept us-gaap:UnrealizedGainLossOnInvestments.

The official record: CryoPort, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about CryoPort, Inc.'s unrealized gain (loss) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CryoPort, Inc.'s unrealized gain (loss) on investments?
CryoPort, Inc. (CYRX) reported unrealized gain (loss) on investments of -$1.06M in Q1 2026.
How has CryoPort, Inc.'s unrealized gain (loss) on investments changed year-over-year?
CryoPort, Inc.'s unrealized gain (loss) on investments decreased by 261.2% year-over-year, from $659K to -$1.06M.
What is the long-term trend for CryoPort, Inc.'s unrealized gain (loss) on investments?
Over 2 years (2021 to 2024), CryoPort, Inc.'s unrealized gain (loss) on investments has grown at a -22.4% compound annual growth rate (CAGR), from -$1.49M to -$899K.